- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05747417
Prismatic Correction for Improving Near Visual Acuity in Patients With Maculopathy
February 17, 2023 updated by: Mehreen Tanveer, Al-Shifa Trust Eye Hospital
patients with maculopathy reported in low vision clinic are tested for prismatic glasses for near vision.
The pre and post visual acuity was recorded.
Study Overview
Detailed Description
Diagnosed patient of maculopathy who was visited in low vision clinic are divided in two groups , one is control group (prescribed simple near vision glasses) and other is interventional group(prescribed prismatic glasses).
Both groups were follow up after one month to check the improvement in near visual acuity
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan
- Al Shifa Trust Eye Hospital Rawalpindi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed patients of maculopathy refer to low vision clinic
- Patients with both genders
- VA from LogMAR 1.0 to LogMAR 0.3
Exclusion Criteria:
- Maculopathy patients with other ocular disease
- VA worsen the LogMAR 1.0
- Patients with mental illness and other physical lmitations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: prism glasses
prisms glasses are advised with ranging of 4prism diopters to 10 prism diopters
|
prism glasses ranging from 4-10 prism diopters
|
No Intervention: presbyopic glasses
simple presbyopia glasses according to age are advised
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prismatic Correction for Improving Near Visual Acuity in Patients with Maculopathy
Time Frame: 7 -8 months
|
A Per forma/questionnaire is used to document Near visual Acuity with the help of light house Chart to see improvement in visual acuity
|
7 -8 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
January 25, 2023
First Submitted That Met QC Criteria
February 17, 2023
First Posted (Estimate)
February 28, 2023
Study Record Updates
Last Update Posted (Estimate)
February 28, 2023
Last Update Submitted That Met QC Criteria
February 17, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AlShifaTrust Eye
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Acuity
-
Alcon ResearchQueensland University of TechnologyRecruiting
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchCompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
Clinical Trials on prismatic glasses
-
Vision Specialists of BirminghamEssilor InternationalTerminatedVertical Heterophoria | Binocular Dysfunction | Vision, Binocular | Vision DisparityUnited States
-
Université Catholique de LouvainCompletedCerebral PalsyBelgium
-
Hospices Civils de LyonInstitut National de la Santé Et de la Recherche Médicale, France; Centre National... and other collaboratorsRecruitingChronic Right Supratensorial Stroke PatientsFrance
-
IRCCS Centro Neurolesi "Bonino-Pulejo"Not yet recruitingParkinson Disease | Visuospatial/Perceptual Abilities | Alexithymia
-
Istituti Clinici Scientifici Maugeri SpAAzienda USL Toscana Sud EstRecruiting
-
Essilor InternationalQueensland University of TechnologyCompleted
-
Hospices Civils de LyonRecruiting
-
Istituti Clinici Scientifici Maugeri SpAUniversity of BolognaCompleted
-
Children's Hospital of Fudan UniversityActive, not recruiting